PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.\', \'Clinical Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.\', \'Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.\', \'Clinical Department of Pneumology, University Hospitals Leuven, Leuven, Belgium.\', \'Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.\', \'Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: pieter.vermeersch@uzleuven.be.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1386-6532(21)00032-910.1016/j.jcv.2021.104765
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 33636554
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all